Nir Erdinest

844 total citations
50 papers, 525 citations indexed

About

Nir Erdinest is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nir Erdinest has authored 50 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Ophthalmology and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nir Erdinest's work include Corneal surgery and disorders (26 papers), Ocular Surface and Contact Lens (23 papers) and Ophthalmology and Visual Impairment Studies (18 papers). Nir Erdinest is often cited by papers focused on Corneal surgery and disorders (26 papers), Ocular Surface and Contact Lens (23 papers) and Ophthalmology and Visual Impairment Studies (18 papers). Nir Erdinest collaborates with scholars based in Israel, United States and United Kingdom. Nir Erdinest's co-authors include Abraham Solomon, N. London, Haim Ovadia, Yair Morad, Itay Lavy, Yoni Grossman, David Landau, Eran Pras, Hadas Mechoulam and Claudia Yahalom and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and Journal of Clinical Medicine.

In The Last Decade

Nir Erdinest

47 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nir Erdinest Israel 13 246 217 180 158 46 50 525
Ewa Mrukwa–Kominek Poland 14 180 0.7× 137 0.6× 233 1.3× 68 0.4× 28 0.6× 78 478
Yasunori Nagaki Japan 15 136 0.6× 88 0.4× 371 2.1× 48 0.3× 39 0.8× 50 766
Yücel Karakurt Türkiye 14 139 0.6× 52 0.2× 186 1.0× 66 0.4× 59 1.3× 27 381
Sebastiano Giuffrida Italy 9 165 0.7× 412 1.9× 167 0.9× 9 0.1× 114 2.5× 23 538
Carlos Carpena‐Torres Spain 10 149 0.6× 152 0.7× 142 0.8× 117 0.7× 6 0.1× 34 387
Céline Portal France 9 49 0.2× 81 0.4× 37 0.2× 31 0.2× 13 0.3× 16 367
Cédric Benoist d’Azy France 4 88 0.4× 76 0.4× 175 1.0× 18 0.1× 53 1.2× 6 320
Jimmy Shiu Ming Lai Hong Kong 14 272 1.1× 139 0.6× 421 2.3× 75 0.5× 8 0.2× 45 694
Marko Oydanich United States 12 29 0.1× 61 0.3× 38 0.2× 44 0.3× 21 0.5× 34 443
Seong-Wook Seo South Korea 12 88 0.4× 50 0.2× 141 0.8× 55 0.3× 12 0.3× 33 319

Countries citing papers authored by Nir Erdinest

Since Specialization
Citations

This map shows the geographic impact of Nir Erdinest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Erdinest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Erdinest more than expected).

Fields of papers citing papers by Nir Erdinest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir Erdinest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Erdinest. The network helps show where Nir Erdinest may publish in the future.

Co-authorship network of co-authors of Nir Erdinest

This figure shows the co-authorship network connecting the top 25 collaborators of Nir Erdinest. A scholar is included among the top collaborators of Nir Erdinest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nir Erdinest. Nir Erdinest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdinest, Nir, et al.. (2025). Clinical Evaluation of Ripasudil for Corneal Edema: A Large-Scale Retrospective Cohort Study. Journal of Clinical Medicine. 14(15). 5572–5572.
2.
Erdinest, Nir, et al.. (2025). Managing pseudophakic bullous keratopathy with a topical rho kinase inhibitor: a case series. Journal of Medical Case Reports. 19(1). 214–214. 2 indexed citations
3.
Erdinest, Nir, Asaf Shemer, Moshe Y. Vardi, et al.. (2025). Changes in Axial Length and Refraction After Gradual Versus Prompt Cessation of Atropine 0.01% Treatment for Myopia Management. Current Eye Research. 51(2). 198–205.
4.
Erdinest, Nir, Moshe Y. Vardi, N. London, et al.. (2024). Treatment of Rapid Progression of Myopia: Topical Atropine 0.05% and MF60 Contact Lenses. Vision. 8(1). 3–3. 3 indexed citations
5.
Erdinest, Nir, et al.. (2024). Higher order aberrations in keratoconus. International Ophthalmology. 44(1). 172–172. 3 indexed citations
6.
Erdinest, Nir, Itay Lavy, N. London, et al.. (2024). [ADDITION OF LOW-CONCENTRATION ATROPINE IN COMBINATION OF DUAL-FOCUS CONTACT LENSES FOR MYOPIA CONTROL TREATMENT].. PubMed. 163(5). 278–285. 1 indexed citations
7.
Smadja, David, Nir Erdinest, Yishay Weill, et al.. (2023). Early Impact of Laser Vision Correction (LVC) on the Stability and Quality of the Retinal Image. Journal of Clinical Medicine. 12(5). 1779–1779. 3 indexed citations
9.
Erdinest, Nir, et al.. (2023). Evaluating the Effect of a Myopia Control Spectacle Lens Among Children in Israel: 12-Month Results. American Journal of Ophthalmology. 257. 103–112. 11 indexed citations
10.
Erdinest, Nir, et al.. (2021). Quadrant Asymmetric Design Contact Lens for Visual Rehabilitation after Eye Trauma. Case Reports in Ophthalmology. 12(2). 330–336. 3 indexed citations
11.
Erdinest, Nir, et al.. (2021). Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography. American Journal of Ophthalmology Case Reports. 25. 101242–101242. 5 indexed citations
12.
Erdinest, Nir, et al.. (2021). Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series. Case Reports in Ophthalmology. 12(2). 548–554. 6 indexed citations
13.
Erdinest, Nir & N. London. (2021). Dynamic visual acuity and methods of measurement. Journal of Optometry. 15(3). 247–248. 7 indexed citations
14.
Erdinest, Nir, et al.. (2021). Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns. Contact Lens and Anterior Eye. 45(4). 101475–101475. 18 indexed citations
15.
Erdinest, Nir & Abraham Solomon. (2014). Topical immunomodulators in the management of allergic eye diseases. Current Opinion in Allergy and Clinical Immunology. 14(5). 457–463. 24 indexed citations
16.
Erdinest, Nir, Eli Moallem, Irene Anteby, et al.. (2014). Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts. Journal of Inflammation. 11(1). 3–3. 20 indexed citations
17.
Erdinest, Nir, et al.. (2014). Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. Journal of Inflammation. 11(1). 6–6. 26 indexed citations
18.
Erdinest, Nir, et al.. (2012). Contact Lens Complications. Elsevier eBooks. 161(6). 371–377. 4 indexed citations
19.
Erdinest, Nir, et al.. (2012). Anti-Inflammatory Effects of Alpha Linolenic Acid on Human Corneal Epithelial Cells. Investigative Ophthalmology & Visual Science. 53(8). 4396–4396. 97 indexed citations
20.
Erdinest, Nir, et al.. (2012). Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells. Contact Lens and Anterior Eye. 35. e16–e17. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026